Kitov to Present Preclinical Data on NT219 at American Association of Cancer Research Virtual Annual Meeting II
Company Expects to Initiate Phase 1/2 Trial of NT-219 as Monotherapy Treatment of Advanced Solid Tumors and in Combination with cetuximab for […]